RIVN insider buying and SEC filings, explained
Rivian Automotive, Inc. / DE · CIK 1874178
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$277K
Insiders who bought
2
Sold (not marked 10b5-1)
$83K
Planned sales (10b5-1)
$7.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 1, 2026 | Planned (10b5-1) | Michael John Callahan (Chief Administrative Officer) sold 15,000 shares at $15.00 ($225K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,001,776 shares. | SEC filing Filed Oct 2, 2026, 5:51 PM ET |
| Sep 11, 2026 | Planned (10b5-1) | Michael John Callahan (Chief Administrative Officer) sold 15,000 shares at about $16.29 ($244K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,016,776 shares. | SEC filing Filed Sep 16, 2026 |
| Aug 20, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 8,023 shares at $16.00 ($128K), marked as a 10b5-1 plan trade. Holdings down 1% to 819,178 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 18, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 13,144 shares at about $14.50 ($191K), marked as a 10b5-1 plan trade. Holdings down 2% to 827,201 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Karen Boone (Director) sold 20,000 shares indirectly at $20.00 ($400K), marked as a 10b5-1 plan trade. Indirect holdings down 15% to 110,000 shares. | SEC filing Filed Jul 8, 2026 |
| Jun 3, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 8,022 shares at $18.00 ($144K), marked as a 10b5-1 plan trade. Holdings down 1% to 878,985 shares. | SEC filing Filed Jun 5, 2026 |
| May 29, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 8,023 shares at $16.00 ($128K), marked as a 10b5-1 plan trade. Holdings down 1% to 887,007 shares. | SEC filing Filed Jun 2, 2026 |
| May 28, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 34,818 shares at $15.00 ($522K), marked as a 10b5-1 plan trade. Holdings down 4% to 922,286 shares. | SEC filing Filed May 29, 2026 |
| May 21, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 7,600 shares at $14.00 ($106K), marked as a 10b5-1 plan trade. Holdings down 1% to 895,030 shares. | SEC filing Filed May 22, 2026 |
| May 15, 2026 | Purchase (code P) | Aidan N. Gomez (Director) bought 18,000 shares at $13.97 ($251K), reported as a purchase (code P). Holdings up 45% to 57,984 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 18, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 5,544 shares at about $13.43 ($74K), marked as a 10b5-1 plan trade. Holdings down 1% to 902,630 shares. | SEC filing Filed May 19, 2026 |
| Apr 22, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 10,245 shares at $18.00 ($184K), marked as a 10b5-1 plan trade. Holdings down 1% to 946,814 shares. | SEC filing Filed Apr 24, 2026 |
| Apr 14, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 21,446 shares at about $16.17 ($347K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,001,138 shares. | SEC filing Filed Apr 16, 2026 |
| Mar 31, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 20,264 shares at $15.00 ($304K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,022,584 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $15.60 ($272K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,042,848 shares. | SEC filing Filed Mar 19, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at $15.00 ($262K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,027,281 shares. | SEC filing Filed Mar 5, 2026 |
| Jan 26, 2022–Oct 23, 2023 | Sale | Jay T. Flatley (Director) sold 580 shares between Jan 26, 2022 and Oct 23, 2023 at about $20.30 ($12K). Holdings down <1% to 160,820 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Jan 11, 2022–Apr 17, 2024 | Purchase (code P) | Jay T. Flatley (Director) bought 1,830 shares between Jan 11, 2022 and Apr 17, 2024 at about $13.81 ($25K), reported as a purchase (code P). Holdings up 1% to 162,070 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 34,900 shares at about $16.80 ($586K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,044,731 shares. | SEC filing Filed Feb 18, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Claire McDonough (CFO) sold 27,133 shares at about $16.80 ($456K), marked as a 10b5-1 plan trade. Holdings down 4% to 680,836 shares. | SEC filing Filed Feb 18, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $16.03 ($280K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,115,209 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 6, 2026 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $19.54 ($341K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,132,659 shares. | SEC filing Filed Jan 8, 2026 |
| Dec 23, 2025 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $21.43 ($374K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,150,109 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 15, 2025 | Sale | Peter Krawiec (Director) sold 3,655 shares indirectly (by trust) at about $19.45 ($71K). Holdings by trust down 11% to 29,122 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Dec 9, 2025 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $17.53 ($306K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,167,559 shares. | SEC filing Filed Dec 11, 2025 |
| Dec 2–4, 2025 | Planned (10b5-1) | Claire McDonough (CFO) sold 29,249 shares between Dec 2, 2025 and Dec 4, 2025 at about $17.38 ($508K), marked as a 10b5-1 plan trade. Holdings down 4% to 730,017 shares. | SEC filing Filed Dec 4, 2025 |
| Nov 25, 2025 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 17,450 shares at about $15.11 ($264K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,185,009 shares. | SEC filing Filed Nov 28, 2025 |
| Nov 11, 2025 | Planned (10b5-1) | Robert J Scaringe (CEO and Director) sold 52,350 shares at about $16.60 ($869K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,246,405 shares. | SEC filing Filed Nov 13, 2025 |
50 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RIVN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.